Pharmacology News and Research

Latest Pharmacology News and Research

Scientists release recommendations for evaluating pharmacological safety of oligonucleotide therapeutics

Novel oligonucleotide-based drugs in development offer promising alternatives for treating a range of diseases.

8 Jul 2014

Researchers identify genetic mutation that may cause parkinsonism in young people

Researchers at the University of Copenhagen and the Copenhagen University Hospital have identified a particular genetic mutation that may cause parkinsonism in young people. The mutation interferes with the brain's transport of the important signal substance dopamine and may also plays a role in mental diseases, e.g. ADHD.

3 Jul 2014

Omega-3 PUFAs offer an affordable way to reduce effects of traumatic brain, spinal cord injuries

The omega-3 polyunsaturated fatty acids (PUFAs) found in seafood and marine oils called EPA and DHA may offer a simple, affordable way to reduce the effects of traumatic brain and spinal cord injuries by decreasing inflammation and nerve cell damage.

30 Jun 2014

INTEGRA introduces Row Dilution Plate Holder accessory for VIAFLO 96 and 384 handheld benchtop pipettes

INTEGRA has introduced a Row Dilution Plate Holder accessory for its VIAFLO 96 and 384 handheld benchtop pipettes.

From INTEGRA Biosciences 30 Jun 2014

Members of JUGGLE network collaborate to improve project coordination

The field of life sciences is at the crossroads of biology and medicine and is a key component of the research portfolio of Johannes Gutenberg University Mainz (JGU).

28 Jun 2014

Child maltreatment increases vulnerability to alcohol consumption when reaching adolescence

A study coordinated by Jorge Manzanares, Professor of Pharmacology at the University Miguel Hernández (UMH) in Elche (Spain), shows that child maltreatment, whatever its form, produces functional brain changes that increase vulnerability to alcohol consumption when reaching adolescence.

28 Jun 2014

Molecule that blocks bone destruction could provide potential therapeutic target for osteoporosis

UT-Southwestern cancer researchers have identified a promising molecule that blocks bone destruction and, therefore, could provide a potential therapeutic target for osteoporosis and bone metastases of cancer.

26 Jun 2014

University of Maryland School of Medicine receives NIH grant to establish neuroscience research center

The University of Maryland School of Medicine's Maryland Psychiatric Research Center, a research center in the School's Department of Psychiatry, was awarded a $10.7 million grant from the National Institutes of Health to establish a Silvio O. Conte Neuroscience Research Center that will examine the causes of schizophrenia and search for possible new treatments.

25 Jun 2014

Small antioxidant molecules suppress colon cancer associated with colitis

Researchers from Case Western Reserve and Dartmouth universities have shown that a class of small antioxidant molecules carries enormous promise for supressing colon cancer associated with colitis.

25 Jun 2014

Cardium reports positive results from Generx Ad5FGF-4 Phase 3 study for treatment of myocardial ischemia

Taxus Cardium Pharmaceuticals Group Inc. will report today at the Biotechnology Industry Organization’s 2014 BIO International Convention on a pre-specified interim analysis from its international ASPIRE Phase 3 registration clinical study of Generx Ad5FGF-4, Cardium Therapeutics’ angiogenic gene therapy product candidate for patients with myocardial ischemia due to coronary artery disease.

25 Jun 2014

Alcoholic liver disease: an interview with Dr Vinood Patel, University of Westminster

Alcoholic liver disease (ALD) is one of the leading causes of death worldwide and also in the UK. As its name indicates this disease arises due to consuming excessive amounts of alcohol (80 g/day) over an extended period, normally 10-20 years.

24 Jun 2014

Trevena's Phase 1b data for TRV130 published in the journal Pain

Trevena, Inc., a clinical stage biopharmaceutical company and the leader in the discovery of G protein coupled receptor (GPCR) biased ligands, today announced the publication of its Phase 1b data for TRV130 in the journal Pain.

24 Jun 2014

Pew, Stewart Trust announce new scholars program for cancer research

The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced the inaugural class of Pew-Stewart Scholars for Cancer Research. Five promising early-career scientists will receive funding for research aimed at finding cures for cancer using approaches that include genetics, pharmacology, and structural biology.

24 Jun 2014

Scientists turn to old class of antibiotics to fight superbugs resistant to modern medicine

Scientists at the University at Buffalo are turning to an old class of antibiotics to fight new superbugs resistant to modern medicine.

24 Jun 2014

Clusters of protein linked to cancer warp cell membranes

Supercomputer simulations have shown that clusters of a protein linked to cancer warp cell membranes, according to scientists at The University of Texas Health Science Center at Houston (UTHealth) Medical School.

24 Jun 2014

Complementary medicines: an interview with Associate Professor Evelin Tiralongo, Griffith University

Complementary medicines are generally being defined as medicines which are non-mainstream medicines and are mostly given together with conventional medicines.

23 Jun 2014

New driver of atherosclerosis may prove to be promising therapeutic target

A new driver of atherosclerosis has been identified by researchers at UT Southwestern Medical Center. This molecule, known as 27HC (27-hydroxycholesterol), has been found to exacerbate the development of the condition, and may prove to be a promising therapeutic target.

20 Jun 2014

Pharmacology News and Research

Latest Pharmacology News and Research

Scientists release recommendations for evaluating pharmacological safety of oligonucleotide therapeutics

Researchers identify genetic mutation that may cause parkinsonism in young people

Omega-3 PUFAs offer an affordable way to reduce effects of traumatic brain, spinal cord injuries

INTEGRA introduces Row Dilution Plate Holder accessory for VIAFLO 96 and 384 handheld benchtop pipettes

Members of JUGGLE network collaborate to improve project coordination

Child maltreatment increases vulnerability to alcohol consumption when reaching adolescence

Molecule that blocks bone destruction could provide potential therapeutic target for osteoporosis

University of Maryland School of Medicine receives NIH grant to establish neuroscience research center

Small antioxidant molecules suppress colon cancer associated with colitis

Cardium reports positive results from Generx Ad5FGF-4 Phase 3 study for treatment of myocardial ischemia

Alcoholic liver disease: an interview with Dr Vinood Patel, University of Westminster

Trevena's Phase 1b data for TRV130 published in the journal Pain

Pew, Stewart Trust announce new scholars program for cancer research

Scientists turn to old class of antibiotics to fight superbugs resistant to modern medicine

Clusters of protein linked to cancer warp cell membranes

Complementary medicines: an interview with Associate Professor Evelin Tiralongo, Griffith University

New driver of atherosclerosis may prove to be promising therapeutic target

New strategy for treating neuroblastoma using modified version of heparin

Failing dopamine pump damages brain cells of patients with Parkinson's disease

Gluten-free diet can improve 'brain fog' in individuals with celiac disease

Pittcon Highlights: Pharmaceutical & Biologic eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Pharmacology News and Research

Latest Pharmacology News and Research

Pittcon Highlights: Pharmaceutical & Biologic eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in